Surgepays is trading 6.31% higher at $0.14 after announcing it received an additional 180 days, until March 22, 2027, to regain Nasdaq’s $1.00 minimum-bid-price compliance.
- The company separately regained compliance with Nasdaq’s stockholders’ equity requirement.
- The broader market was lower, so it does not explain the gain; available reporting provides limited confirmation of intraday trading activity.